Silexion Therapeutics Corp SEC filings SLXNW
Silexion Therapeutics Corp has 279 filings in SEC EDGAR's recent list, going back to May 9, 2024. Its latest annual report, Form 10-K, was filed on Mar 17, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 26, 2026 (bylaw or fiscal year change, shareholder vote results). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Oct 26, 2026 | Oct 26, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 30, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Sep 29, 2026 | Sep 28, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 28, 2026 | Sep 28, 2026 |
| 8-K |
Current report
Listing notice
|
Sep 25, 2026 | Sep 25, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Sep 25, 2026 | Sep 25, 2026 |
| 8-K |
Current report
Listing notice
|
Aug 21, 2026 | Aug 21, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2026 | Aug 14, 2026 |
| 8-K |
Current report
Other events
|
Aug 13, 2026 | Aug 13, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Aug 13, 2026 | Aug 13, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 10, 2026 | Aug 10, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 4, 2026 | Aug 4, 2026 |
| 8-K |
Current report
Other events
|
Aug 3, 2026 | Aug 3, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 31, 2026 | Jul 31, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 29, 2026 | Jul 29, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jul 21, 2026 | Jul 21, 2026 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
May 29, 2026 | May 29, 2026 |
| 8-K |
Current report
Other events
|
May 26, 2026 | May 26, 2026 |
| 8-K |
Current report
Results of operations
|
May 18, 2026 | May 18, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
May 15, 2026 | May 15, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
May 14, 2026 | May 14, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
May 13, 2026 | May 13, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
May 5, 2026 | May 5, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 28, 2026 | Apr 28, 2026 |
| 8-K |
Current report
Officer or director change
|
Mar 25, 2026 | Mar 25, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 24, 2026 | Mar 24, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Mar 23, 2026 | Mar 23, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 3, 2026 | Feb 3, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 6, 2026 | Jan 6, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 16, 2025 | Dec 16, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 2, 2025 | Dec 2, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 25, 2025 | Nov 25, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2025 | Nov 12, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 30, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Material agreement
|
Sep 26, 2025 | Sep 26, 2025 |
| 8-K |
Current report
Other events
|
Sep 25, 2025 | Sep 25, 2025 |
| 8-K |
Current report
Unregistered share sale, Other events
|
Sep 15, 2025 | Sep 15, 2025 |
| 8-K |
Current report
Material agreement
|
Sep 12, 2025 | Sep 11, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 11, 2025 | Sep 11, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 4, 2025 | Sep 4, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 2, 2025 | Sep 2, 2025 |
| 8-K |
Current report
Other events
|
Aug 20, 2025 | Aug 20, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Aug 19, 2025 | Aug 19, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2025 | Aug 12, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Aug 1, 2025 | Aug 1, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 31, 2025 | Jul 31, 2025 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Jul 29, 2025 | Jul 29, 2025 |
| 8-K |
Current report
Listing notice
|
Jul 21, 2025 | Jul 21, 2025 |
| 8-K |
Current report
Other events
|
Jul 16, 2025 | Jul 16, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jul 14, 2025 | Jul 14, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 9, 2025 | Jul 9, 2025 |
| 8-K/A |
Amended current report
Other events
|
Jul 8, 2025 | Jul 8, 2025 |
| 8-K |
Current report
Other events
|
Jul 8, 2025 | Jul 8, 2025 |
| 8-K |
Current report
Other events
|
Jun 3, 2025 | Jun 3, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
May 29, 2025 | May 29, 2025 |
| 8-K |
Current report
Listing notice
|
May 23, 2025 | May 23, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
May 21, 2025 | May 21, 2025 |
| 8-K |
Current report
Results of operations
|
May 13, 2025 | May 13, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 23, 2025 | Apr 23, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 28, 2025 | Mar 28, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 18, 2025 | Mar 18, 2025 |
| 8-K |
Current report
Material agreement
|
Mar 14, 2025 | Mar 14, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 5, 2025 | Mar 5, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jan 30, 2025 | Jan 29, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 28, 2025 | Jan 28, 2025 |
| 8-K |
Current report
Material agreement
|
Jan 17, 2025 | Jan 15, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jan 15, 2025 | Jan 15, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 15, 2025 | Jan 15, 2025 |
| 8-K |
Current report
Results of operations
|
Jan 14, 2025 | Jan 14, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 17, 2024 | Dec 17, 2024 |
| 8-K |
Current report
Other events
|
Dec 16, 2024 | Dec 16, 2024 |
| 8-K |
Current report
Officer or director change
|
Dec 10, 2024 | Dec 10, 2024 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Nov 29, 2024 | Nov 29, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 27, 2024 | Nov 27, 2024 |
| 8-K |
Current report
Listing notice, Other events
|
Nov 22, 2024 | Nov 22, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Nov 19, 2024 | Nov 19, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2024 | Nov 14, 2024 |
| 8-K |
Current report
Listing notice
|
Nov 1, 2024 | Nov 1, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 1, 2024 | Oct 1, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 24, 2024 | Sep 24, 2024 |
| 8-K |
Current report
Officer or director change
|
Sep 19, 2024 | Sep 16, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 9, 2024 | Sep 9, 2024 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, New debt, Unregistered share sale, Change to shareholder rights, Change in control, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
|
Aug 21, 2024 | Aug 15, 2024 |
Showing 83 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- SLXN (Nasdaq), SLXNW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- Ramat Gan, Israel
- SEC filer status
- , Emerging growth company
- SEC CIK
- 2022416
- Former names
- Biomotion Sciences (until Aug 15, 2024)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.